M. Otaola (Ciudad Autónoma Buenos Aires, Argentina), J. Porter (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review
M. Althobiani (London, United Kingdom), R. Evans (London, United Kingdom), J. Alqahtani (London, United Kingdom), A. Aldhahir (London, United Kingdom), J. Hurst (London, United Kingdom), J. Porter (London, United Kingdom)
|   |
Morbidity and mortality following surgical lung biopsy in interstitial lung disease in a specialized multidisciplinary center.
V. Menezes (Montreal, Canada), C. Pollock (Montreal, Canada), A. Jouquan (Montreal, Canada), J. Morisset (Montreal, Canada), C. Leduc (Montreal, Canada), P. Romeo (Montreal, Canada), H. Manganas (Montreal, Canada), A. Gauthier (Montreal, Canada), P. Ferraro (Montreal, Canada), E. Lafontaine (Montreal, Canada), J. Martin (Montreal, Canada), B. Nasir (Montreal, Canada), M. Liberman (Montreal, Canada)
| |
SADL scale as a predictor of mortality in patients with ILD associated with Scleroderma
V. Parra León (MADRID, Spain), W. Girón Matute (MADRID, Spain), F. Pedraza Serrano (MADRID, Spain), B. Serrano Benavente (MADRID, Spain), C. Castro Riera (MADRID, Spain), L. Puente Maestú (MADRID, Spain)
| |
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
M. Berger (Cologne, Germany), M. Wollsching-Strobel (Cologne, Germany), E. Bünemann (Cologne, Germany), S. Schwarz (Cologne, Germany), D. Majorski (Cologne, Germany), T. Mathes (Cologne, Germany), W. Windisch (Cologne, Germany)
| |
Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
K. Furuta (WakayamaCity, Japan), D. Fujimoto (WakayamaCity, Japan), A. Matsunashi (KobeCity, Japan), M. Tanaka (WakayamaCity, Japan), R. Shibaki (WakayamaCity, Japan), Y. Shimada (KobeCity, Japan), K. Nagata (KobeCity, Japan), K. Tomii (KobeCity, Japan), N. Yamamoto (WakayamaCity, Japan)
| |
Progressive fibrosing interstitial lung disease (PF-ILD) in six referral centers in Brazil
P. Cavalcante Neto (São Paulo, Brazil), A. Carolina Lima Resende (São Paulo, Brazil), E. Viana Mancuzo (Belo Horizonte, Brazil), M. Raquel Soares (Sao Paulo, Brazil), M. Auxiliadora Moreira (Goiania, Brazil), L. Ferreira Neves Arantes (Goiania, Brazil), R. Celia Carlos Tibana (Sao Paulo, Brazil), F. Maciel De Aguiar Baptista (Salvador, Brazil), T. Senna Galvão Nonato Alves (Salvador, Brazil), K. Mueller Storrer (Curitiba, Brazil), P. Isolani De Oliveira (Sao Paulo, Brazil), F. Maria Pinheiro Machado Nogueira (Sao Paulo, Brazil), R. Boaventura Martins (Sao Paulo, Brazil), S. Lobo Krupok Matias (Sao Paulo, Brazil), S. Abou El Hosn Cordero Da Silva (Sao Paulo, Brazil), V. El Mir Arida (Sao Paulo, Brazil), A. Bezerra Botelho (Sao Paulo, Brazil), B. Leoncio De Moraes Beraldo (Sao Paulo, Brazil), M. Dornfeld Cunha Castro (Sao Paulo, Brazil), C. Yoshito Fukuda (Sao Paulo, Brazil), M. Tenório Cerezoli (Sao Paulo, Brazil), R. Gomes Ferreira (Sao Paulo, Brazil), I. Missrie (Sao Paulo, Brazil), C. Pereira (Sao Paulo, Brazil)
| |
Analyses of predictive findings indicative of progressive interstitial lung diseases
S. Abou El Hosn Cordero Da Silva (Sao Paulo , Brazil), A. Carolina Lima Resende (Sao Paulo , Brazil), E. Viana Mancuzo (Minas Gerais , Brazil), M. Raquel Soares (Sao Paulo, Brazil), M. Auxiliadora Moreira (Goiania, Brazil), P. Miranda Cavalcante Neto (Sao Paulo, Brazil), L. Ferreira Neves Arantes (Goiania, Brazil), R. Célia Carlos Tibana (Sao Paulo, Brazil), F. Maciel De Aguiar Baptista (Salvador, Brazil), T. Senna Galvão Nonato Alves (Salvador, Brazil), K. Mueller Storrer (Curitiba, Brazil), P. Isolani De Oliveira (Sao Paulo, Brazil), F. Maria Pinheiro Machado Nogueira (Sao Paulo, Brazil), R. Boaventura Martins (Sao Paulo, Brazil), S. Lobo Krupok Matias (Sao Paulo, Brazil), V. El Mir Arida (Sao Paulo, Brazil), A. Bezerra Botelho (Sao Paulo, Brazil), B. Leoncio De Moraes Beraldo (Sao Paulo, Brazil), M. Dornfeld Cunha Castro (Sao Paulo, Brazil), C. Yoshito Fukuda (Sao Paulo, Brazil), M. Tenório Cerezoli (Sao Paulo, Brazil), R. Gomes Ferreira (Sao Paulo, Brazil), I. Missrie (Sao Paulo, Brazil), C. Pereira (Sao Paulo, Brazil)
| |
Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
G. Jeanniard (Nantes, France), M. Nasser (Lyon, France), S. Turquier (Lyon, France), K. Ahmad (Lyon, France), J. Calabuig Lopez (Lyon, France), J. Glérant (Lyon, France), J. Traclet (Lyon, France), A. Chambellan (Nantes, France), V. Cottin (Lyon, France)
| |
Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
C. Diou (Paris, France), M. Debray (Paris, France), C. Bancal (Paris, France), K. Sacré (Paris, France), C. Taillé (Paris, France), W. Khamis (Bobigny, France), R. Dhote (Bobigny, France), R. Borie (Paris, France), H. Nunes (Bobigny, France), Y. Uzunhan (Bobigny, France), B. Crestani (Paris, France)
| |
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
T. Karampitsakos (Patras, Greece), O. Papaioannou (Patras, Greece), S. Chrysikos (Athens, Greece), M. Katsaras (Patras, Greece), G. Tsirikos (Patras, Greece), P. Tsiri (Patras, Greece), E. Zarkadi (Patras, Greece), P. Efthymiou (Patras, Greece), V. Sotiropoulou (Patras, Greece), N. Ntoulias (Patras, Greece), E. Malakounidou (Patras, Greece), A. Bellou (Patras, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), F. Sampsonas (Patras, Greece), T. Karageorgas (Athens, Greece), K. Dimakou (Athens, Greece), D. Bouros (Athens, Greece), A. Tzouvelekis (Patras, Greece)
| |
Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD
C. Stock (London, United Kingdom), M. Kokosi (London, United Kingdom), V. Alfieri (Parma, Italy), V. Kouranos (London, United Kingdom), P. George (London, United Kingdom), P. Molyneaux (London, United Kingdom), F. Chua (London, United Kingdom), B. Seeliger (Hannover, Germany), V. Ong (London, United Kingdom), D. Abraham (London, United Kingdom), T. Witte (Hannover, Germany), C. Denton (London, United Kingdom), A. Prasse (Hannover, Germany), A. Wells (London, United Kingdom), E. Renzoni (London, United Kingdom)
| |
Clinical spectrum and outcome of non IPF patients with a typical UIP picture
J. Naftel (Portsmouth, United Kingdom), M. Mottershaw (Portsmouth, United Kingdom), K. Strickland (Portsmouth, United Kingdom), A. Wallis (Portsmouth, United Kingdom), P. Mcparland (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), S. Babu (Portsmouth, United Kingdom)
| |
Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort
A. Gouveia Cardoso (Porto, Portugal), L. Mendonça Almeida (Porto, Portugal), A. Fernandes (Porto, Portugal), B. Lima (Porto, Portugal), I. Neves (Porto, Portugal), H. Novais Bastos (Porto, Portugal), P. Caetano Mota (Porto, Portugal), N. Melo (Porto, Portugal), C. Souto Moura (Porto, Portugal), S. Guimarães (Porto, Portugal), A. Carvalho (Porto, Portugal), R. Cunha (Porto, Portugal), J. Pereira (Porto, Portugal), A. Morais (Porto, Portugal)
| |
Predictive Findings of survival in Familiar Pulmonary fibrosis
E. Viana Mancuzo (Belo Horizonte (MG), Brazil), R. Celia Carlos Tibana (São Paulo, Brazil), M. Soares (São Paulo, Brazil), D. Dos Reis Estrella (Belo Horizonte (MG), Brazil), C. Pereira (São Paulo, Brazil)
| |
Connective tissue associated lung disease treated with Cyclophosphamide in Durban, South Africa.
M. Mitha (Durban (Kwa Zulu-Natal), South Africa), S. Singh (Durban (Kwa Zulu-Natal), South Africa), C. Connolly (Durban (Kwa Zulu-Natal), South Africa), K. Nyamande (Durban (Kwa Zulu-Natal), South Africa)
| |
Longitudinal serological assessment of neutrophil activity is related to disease progression in idiopathic pulmonary fibrosis
H. Jessen (Herlev, Denmark), N. Hoyer (Hellerup, Denmark), T. Prior (Aarhus, Denmark), P. Frederiksen (Herlev, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), E. Bendstrup (Aarhus, Denmark), J. Sand (Herlev, Denmark), S. Shaker (Hellerup, Denmark)
| |
Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A. Carolina Lima Resende (SAO PAULO, Brazil), E. Viana Mancuzo (BELO HORIZONTE , Brazil), M. Raquel Soares (SAO PAULO , Brazil), P. Miranda Cavalcante Neto (SAO PAULO , Brazil), M. Auxiliadora Moreira (GOIANIA, Brazil), L. Ferreira Neves Arantes (GOIANIA, Brazil), R. Célia Carlos Tibana (SAO PAULO , Brazil), F. Maciel De Aguiar Baptista (SALVADOR, Brazil), T. Senna Galvão Nonato Alves (SALVADOR, Brazil), K. Mueller Storrer (CURITIBA, Brazil), P. Isolani De Oliveira (SAO PAULO, Brazil), F. Maria Pinheiro Machado Nogueira (SAO PAULO, Brazil), R. Boaventura Martins (SAO PAULO, Brazil), S. Lobo Krupok Matias (SAO PAULO, Brazil), S. Abou El Hosn Cordero Da Silva (SAO PAULO, Brazil), V. El Mir Arida (SAO PAULO, Brazil), A. Bezerra Botelho (SAO PAULO, Brazil), B. Leôncio De Moraes Beraldo (SAO PAULO, Brazil), M. Dornfeld Cunha Castro (SAO PAULO, Brazil), C. Yoshito Fukuda (SAO PAULO, Brazil), M. Tenório Cerezoli (SAO PAULO, Brazil), R. Gomes Ferreira (SAO PAULO, Brazil), I. Missrie (SAO PAULO, Brazil), C. Pereira (SAO PAULO, Brazil)
| |
Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
T. Yamaya (Yokohama city, Japan), E. Hagiwara (Yokohama city, Japan), T. Baba (Yokohama city, Japan), T. Iwasawa (Yokohama city, Japan), T. Ogura (Yokohama city, Japan)
| |
Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients
C. Aloe (Bundoora, Australia), P. Papagianis (Bundoora, Australia), J. Mcqualter (Bundoora, Australia), C. Mcdonald (Heidelberg, Australia), T. Leong (Heidelberg, Australia), N. Goh (Heidelberg, Australia), S. Bozinovski (Bundoora, Australia)
| |
Late Breaking Abstract - Role of shear stress and oxygen toxicity on central nervous system comorbidities in bronchopulmonary dysplasia
L. Haist (Munich, Germany), S. Stöcklein (Munich, Germany), J. Henao Sanchez (Munich, Germany), B. Schubert (Munich, Germany), A. Hilgendorff (Munich, Germany)
| |